英格兰和威尔士功能性单心室先天性心脏病的长期生存与中心手术量
本研究基于英格兰和威尔士2000至2018年出生的功能性单心室先天性心脏病(f-SV CHD)患儿,利用全国先天性心脏病手术登记处进行回顾性队列研究,随访至2020年。在3293例f-SV CHD患儿中,1年生存率为76.8%(95%CI 75.3%-78.2%),5年生存率为72.1%(95%CI 70.6%-73.7%)。调整病例组合后,f-SV中心手术量与长期生存无显著关联(调整后HR 1.01,95%CI 0.99-1.04,P=0.28)。
要点
- 在英格兰和威尔士的集中化医疗服务中,调整病例组合后,f-SV中心手术量与长期生存无显著关联。
- f-SV CHD患儿1年生存率为76.8%(95%CI 75.3%-78.2%),5年生存率为72.1%(95%CI 70.6%-73.7%)。
- 更复杂的f-SV(左心发育不良综合征、Norwood路径)患者更多在f-SV手术量较大的中心接受治疗(P<0.001)。
核心结论
- 调整病例组合后,没有证据表明在英格兰和威尔士10个儿童心脏中心提供的集中化医疗服务中,f-SV中心手术量与长期生存相关。
研究设计与样本
- 回顾性队列研究,纳入2000年至2018年间出生的f-SV CHD患儿,使用全国CHD手术登记处数据,生存状态确认至2020年。
- 共纳入56,039例患者,其中3293例(5.9%)为f-SV CHD;首次干预中位年龄7天(IQR 4-27),中位随访时间7.6年(IQR 1.0-13.3)。
- 最大的诊断亚组为左心发育不良综合征1276例(38.8%)、三尖瓣闭锁440例(13.4%)、左心室双入口322例(9.8%)。
主要发现
- 1年生存率为76.8%(95%CI 75.3%-78.2%),5年生存率为72.1%(95%CI 70.6%-73.7%)。
- 未调整分析中,每中心每年f-SV开始治疗患者每增加5例,风险比HR为1.04(95%CI 1.02-1.06),P<0.001。
- 调整显著危险因素(诊断亚组、产前诊断、首次手术时年龄较小、低体重、获得性合并症、疾病严重程度增加)后,f-SV中心手术量的HR为1.01(95%CI 0.99-1.04),P=0.28。
- 有强证据表明更复杂的f-SV(左心发育不良综合征、Norwood路径)患者在f-SV病例量更大的中心接受治疗(P<0.001)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Long-term survival is an important metric for health care evaluation, especially in functionally single-ventricle (f-SV) congenital heart disease (CHD). This study's aim was to evaluate the relationship between center volume and long-term survival in f-SV CHD within the centralized health care service of England and Wales. METHODS: This was a retrospective cohort study of children born with f-SV CHD between 2000 and 2018, using the national CHD procedure registry, with survival ascertained in 2020. RESULTS: Of 56,039 patients, 3293 (5.9%) had f-SV CHD. Median age at first intervention was 7 days (interquartile range [IQR], 4, 27), and median follow-up time was 7.6 years (IQR, 1.0, 13.3). The largest diagnostic subcategories were hypoplastic left heart syndrome, 1276 (38.8%); tricuspid atresia, 440 (13.4%); and double-inlet left ventricle, 322 (9.8%). The survival rate at 1 year and 5 years was 76.8% (95% confidence interval [CI], 75.3%-78.2%) and 72.1% (95% CI, 70.6%-73.7%), respectively. The unadjusted hazard ratio for each 5 additional patients with f-SV starting treatment per center per year was 1.04 (95% CI, 1.02-1.06), P < .001. However, after adjustment for significant risk factors (diagnostic subcategory; antenatal diagnosis; younger age, low weight, acquired comorbidity, increased severity of illness at first procedure), the hazard ratio for f-SV center volume was 1.01 (95% CI, 0.99-1.04) P = .28. There was strong evidence that patients with more complex f-SV (hypoplastic left heart syndrome, Norwood pathway) were treated at centers with greater f-SV case volume (P < .001). CONCLUSIONS: After adjustment for case mix, there was no evidence that f-SV center volume was linked to longer-term survival in the centralized health service provided by the 10 children's cardiac centers in England and Wales.
引用
- Brown KL, Huang Q, Hadjicosta E, et al. Long-term survival and center volume for functionally single-ventricle congenital heart disease in England and Wales. J Thorac Cardiovasc Surg. 2022. PMID: 36535820. doi:10.1016/j.jtcvs.2022.11.018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。